Purchases and Sales Made in Q2 2025 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q2 2025. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 09, 2025
Q2 2025
|
Sovran Advisors, LLC
San Diego, CA |
BUY
|
- |
39.5KNew |
$597K - $855K
|
39.5K
$887K
|
|
Jul 09, 2025
Q2 2025
|
Mirador Capital Partners LP
|
BUY
|
- |
30.8K+ 24.12% |
$467K - $668K
|
159K
$3.56M
|
|
Jul 07, 2025
Q2 2025
|
Versant Capital Management, Inc
|
BUY
|
- |
126+ 143.18% |
$1.91K - $2.73K
|
214
$4.81K
|
|
Jul 07, 2025
Q2 2025
|
Parallel Advisors, LLC
|
SELL
|
- |
-859- 92.07% |
$13K - $18.6K
|
74
$1.66K
|